Takeda has returned to BridGene Biosciences for another small-molecule collaboration—this time focused on immunology as well as neurology. BridGene’s pursuit of undruggable targets is enabled ...

Takeda’s (NYSE: TAK) (TSE:4502) plasma-derived therapies (PDT) business, led by Giles Platford, president of Takeda’s Plasma-Derived Therapies Business Unit and chair of the Plasma Protein ...

In this article, we are going to take a look at where Takeda Pharmaceutical Company Limited (NYSE:TAK) stands against the other Japanese stocks. As the dangers of natural disasters increase and ...

Kai Trump – the oldest granddaughter of President Donald Trump – picked up a major endorsement in one of the president's favorite sports: golf. Kai Trump, who committed to the University of ...

Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker. Weber – who was briefly chief operating officer of Takeda ...

The final five episodes of Cobra Kai floored me. From the “Thunderstruck” moment at the end of Episode 13 (“Skeletons”) to the Daniel and Johnny Rocky-inspired training montage (featuring ...

On Monday, Protagonist Therapeutics, Inc. (NASDAQ:PTGX) and Takeda Pharmaceutical Co Ltd (NYSE:TAK) released topline results for the Phase 3 VERIFY study of rusfertide for polycythemia vera.

Takeda has bolstered its near-term pipeline in rare haematological disorders by licensing rights to a polycythaemia vera (PV) treatment being developed by Protagonist Therapeutics. The Japanese ...

That's all, folks. Cobra Kai has thrown its last kick in anger and come to a definitive conclusion. But amid the melees, last-minute twists, and deaths, you may be waiting for the dust to settle ...

Cobra Kai's creators clearly aren't ruling out any spin-offs as Hayden Schlossberg reveals the creative team has been working hard on "multiple different possibilities" for future projects.

Cobra Kai never dies but for now the Netflix series is now coming to an end. The final part of Season 6 is scheduled to drop soon and will deal with the aftermath of Miyagi-Do's trip to Spain for ...

January 30, 2025 Drugmaker Takeda's CEO Weber to step down, raises profit forecast Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm ...